INCY
NASDAQ · Biotechnology
Incyte Corp
$119.29
-2.60 (-2.13%)
Performance
1D
-2.13%
1W
+1.45%
1M
+7.12%
3M
-1.23%
6M
+22.19%
1Y
+12.56%
YTD
+17.62%
Open$121.54
Previous Close$121.89
Day High$121.54
Day Low$119.03
52W High$132.60
52W Low$89.25
Volume—
Avg Volume2.13M
Market Cap24.22B
P/E Ratio15.02
EPS$7.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$119.57
Below
SMA 200
$108.53
Above
RSI (14)
57.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
35 analysts
Price Target
+73.4% upside
Current
$119.29
$119.29
Target
$206.81
$206.81
$125.25
$206.81 avg
$260.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.18B | 4.51B | 3.83B |
| Net Income | 1.30B | 1.02B | -346,012,622 |
| Profit Margin | 25.0% | 23.8% | -9.0% |
| EBITDA | 1.55B | 1.29B | -409,317,505 |
| Free Cash Flow | — | — | -346,886,835 |
| Rev Growth | +14.8% | +14.8% | -9.6% |
| Debt/Equity | 0.01 | 0.01 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.16 | +0.29% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.66 | -0.34% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.91 | +0.35% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $550.07 | -0.15% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $911.56 | -0.91% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $151.28 | -3.40% | 7.7 | 20.98B |